Arteris CFO granted 142,835 RSUs at no cost

Arteris’ chief financial officer received a 142,835-unit time-vested RSU equity award with quarterly vesting beginning in 2028.

Rhea-AI Filing Summary

Arteris, Inc. (symbol: AIP) is the issuer of record for a Form 4 filing submitted to the SEC. Sinha Saurabh reported acquisition or exercise transactions in this Form 4 filing.

Arteris, Inc. (AIP) reported that Chief Financial Officer Saurabh Sinha received a grant of 142,835 restricted stock units (RSUs) on September 8, 2026. Each RSU represents a contingent right to receive one share of common stock, and the grant was made at a stated price of $0.00 per unit.

According to the vesting terms, 25% of the RSUs will vest on September 8, 2027, with the remainder vesting pro rata by day on the first day of each of 12 consecutive quarters, aligned with fiscal quarterly vesting commencing January 1, 2028. The RSUs have no expiration date, and no Rule 10b5-1 trading plan is reported for this award.

Insider Trade Summary

Grant/Award: 142,835 shares

Grant/Award 1 txn

Insider Sinha Saurabh

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	142,835	$0.00	$0.00

Holdings After Transaction: Common Stock — 142,835 shares (Direct)

Footnotes (1)

1. F1. Includes 142,835 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 25% of the total RSUs will vest on September 8, 2027, and the remaining will vest pro rata by day on the first day of each 12 consecutive quarters thereafter and aligned with fiscal quarterly vesting commencing in January 1, 2028. The RSUs have no expiration date.

Key Figures

RSUs granted: 142,835 units Grant price per RSU: $0.00 per unit RSUs held after transaction: 142,835 units +2 more

5 metrics

RSUs granted 142,835 units Restricted stock units granted to the CFO on September 8, 2026

Grant price per RSU $0.00 per unit Stated price for the RSU award

RSUs held after transaction 142,835 units Total common-stock-related units directly held after the grant

Initial vesting portion 25% Portion of total RSUs vesting on September 8, 2027

Quarterly vesting periods 12 consecutive quarters Remaining RSUs vest pro rata by day over 12 quarters starting January 1, 2028

Key Terms

restricted stock units ("RSUs"), contingent right, fiscal quarterly vesting

3 terms

restricted stock units ("RSUs") financial

"Includes 142,835 restricted stock units ("RSUs"), each of which represents"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"each of which represents a contingent right to receive one share"

fiscal quarterly vesting financial

"aligned with fiscal quarterly vesting commencing in January 1, 2028"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Arteris (AIP) disclose in this Form 4 for its CFO?

The filing reports that Chief Financial Officer Saurabh Sinha received a grant of 142,835 restricted stock units (RSUs) on September 8, 2026, as equity compensation, all held as a direct interest in Arteris common stock equivalents.

How many RSUs were granted to the Arteris (AIP) CFO and at what price?

The CFO was granted 142,835 RSUs, each representing a contingent right to one share of Arteris common stock, at a stated grant price of $0.00 per unit.

What is the vesting schedule for the 142,835 RSUs at Arteris (AIP)?

25% of the RSUs will vest on September 8, 2027. The remaining units will vest pro rata by day on the first day of each of 12 consecutive quarters, aligned with fiscal quarterly vesting commencing January 1, 2028.

What will the Arteris (AIP) CFO hold after this RSU grant?

Following the reported transaction, the CFO holds 142,835 common-stock-related units directly, consisting of 142,835 RSUs, each representing a contingent right to receive one share of Arteris common stock upon vesting and settlement.

Are the Arteris (AIP) CFO’s RSUs subject to expiration or a 10b5-1 plan?

The RSUs have no expiration date. The filing’s Rule 10b5-1 checkbox is not marked, and there is no indication that this grant was made pursuant to a Rule 10b5-1 trading plan.

What type of security is involved in this Arteris (AIP) Form 4 filing?

The transaction involves Common Stock of Arteris, Inc., in the form of restricted stock units (RSUs), each of which represents a contingent right to receive one share of Arteris common stock, subject to the stated vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:36 PM Accepted by SEC EDGAR 09/10/2026 - 04:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sinha Saurabh

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVENUE SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		A(1)		142,835	A	$0.00	142,835	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 142,835 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 25% of the total RSUs will vest on September 8, 2027, and the remaining will vest pro rata by day on the first day of each 12 consecutive quarters thereafter and aligned with fiscal quarterly vesting commencing in January 1, 2028. The RSUs have no expiration date.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Saurabh Sinha	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)